Abstract:Microscopic polyangiitis (MPA) is a form of necrotizing vasculitis affecting the small vessels. Our study is the first study with the objective of describing the difference in clinical presentation of MPA and response to treatment at 6 months based on the age of disease onset. All patients seen at a tertiary vasculitis clinic between 2015 and 2023 with a diagnosis of MPA were included. Patients were divided into an elderly group (age > = 65 years) and a younger group (age < 65). Comparative analysis was conducted to characterize differences amongst the elderly and younger patients, including differences in organ involvement and clinical presentation, Birmingham Vasculitis Activity Score (BVAS) scores, Vasculitis Damage Index( VDI) scores, and response to treatment at 6 months. Thirty-one patients were included in our study. Younger MPA patients (n = 18) with mean age at diagnosis of 53.17 years were compared with older MPA patients(n = 13) with mean age at diagnosis of 76.08 years. The younger patients had statistically significant higher BVAS scores (p = 0.009), along with higher incidence of renal (p = 0.028), pulmonary (p = 0.0069), and cutaneous (p = 0.026) manifestations at disease onset. Furthermore, amongst the younger population, there was noted statistically significant clinical improvement at 6 months following treatment induction, particularly in the domains of general symptoms (p = 0.011), MSK (p = 0.019), cutaneous (p = 0.011), and pulmonary symptoms (p = 0.04). In contrast, the elderly population presented with a predominant of non-specific constitutional symptoms, with statistically significant improvement in the domain of non-specific general symptoms at 6 months (p = 0.00008). All MPA patients responded well to treatment, with statistically significant improvement amongst younger patients (p = 0.0032), but no statistically significant improvement amongst elderly patients (p = 0.67). Our study findings concluded that MPA's clinical presentation differed by age group. Younger patients had more aggressive vasculitis disease presentation with better response to treatments, whereas, elderly patients had less severe disease presentation with predominant of general symptoms at disease onset. Key Points • MPA clinical presentation differed by age at disease onset. Younger patients presented with more aggressive and classic vasculitis-like presentations, with multi-system organ involvement and statistically significant higher incidence of renal, pulmonary, and cutaneous manifestations. In contrast, elderly patients had a predominant of constitutional and non-specific symptoms with often delayed diagnosis. • All MPA patients responded well to treatment. Amongst the younger population, there was statistically significant improvement in BVAS scores after treatment induction at 6 months; however, there was no statistically significant improvement of BVAS scores in the elderly population. • Future studies are required to further understand the difference in the clinical presentation of MPA based on the age at disease onset, and the implication on disease diagnosis and management.

Manifestation and long-term prognosis in microscopic polyangiitis patients with pulmonary involvement

Chest CT features of microscopic polyangiitis

The Lung Involvement of Microscopic Polyangiitis

The Clinical and Pathological Features of Children With Microscopic Polyangiitis

Long-term Outcome of Mycophenolate Mofetil Treatment for Patients with Microscopic Polyangiitis: an Observational Study in Chinese Patients

Clinical significance of microscopic polyangiitis with interstitial lung disease and bronchiectasis: probability of preexisting comorbidities

Clinical and pathological characterization of patients with microscopic polyangiitis with medium artery involvement.

Long-term clinical course and outcomes of patients with microscopic polyangiitis-associated interstitial lung disease

Lung Involvement of Microscopic Polyangiitis

Long-term survival, causes of death, and prognostic factors for mortality in patients with microscopic polyangiitis and those with anti-neutrophil cytoplasmic antibody-positive interstitial lung disease: A single-center retrospective study

[Clinical Characteristics and Treatment Outcomes of Microscopic Polyangiitis Combined with Autoimmune Hemolytic Anemia].

[Clinical characteristics of 15 cases of microscopic polyangiitis associated with alveolar hemorrhage].

Effects Of Mycophenolate Mofetil Combined With Corticosteroids For Induction Therapy Of Microscopic Polyangiitis

Prognosis of microscopic polyangiitis is well predictable in the first 2 weeks of treatment

[Clinicopathologic Analysis of 34 Patients with Microscopic Polyangitis].

Elderly versus younger patients with microscopic polyangiitis vasculitis (MPA): a single-center retrospective study

Long-term Prognosis in Idiopathic Membranoproliferative Glomerulonephritis

Long-Term Prognostic Factors in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A 15-Year Multicenter Retrospective Study

Pathological Classification and Prognosis of Renal Damage Caused by Antineutrophil Cytoplasmic Antibody Associated Vasculitis

Microscopic polyangiitis initially presenting with idiopathic pulmonary fibrosis: a case report

Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort